Sponsored by Precision ADVANCE, this Endpoints webinar convened leading advanced therapy experts to discuss the future of cell therapy development and delivery. This discussion was moderated by John Khoury: EVP (Project Farma), and included insights from Chris McDonald: Global Head of Tech Ops (Kite Pharma), Mark Frattini: CMO (Cellectis), Jason Foster: CEO & ED (Ori Biotech), and Phil Cyr: SVP (Precision Value & Health).

Key points to be discussed:
  • Explore the latest strategies for navigating the complexities of cell therapy development 
  • Identify clinical development best practices for a successful execution 
  • Learn insights into the cutting-edge advancements that are driving the future of cell therapy